1. Benjamin H, Lebanony D, Rosenwald S, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn. 2010 Nov;12(6):771-9. Epub 2010 Sep 23 

1. Arnon Afek, Kinneret Rosenblatt, Hila Tabibian-Keissar, Merav Zepeniuk, Lahav Cohen, Harel Dan, Orit Zion, Yulia Strenov, Sylvie Polak-Charcon and Marina Perelman. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathology Research and Practice, online publication, 28 April 2010 (doi:10.1016/j.prp2010.03.005)
2. Meiri E, Spector Y, Cohen L, et al. MicroRNAs as powerful diagnostic tools for the differential diagnosis of lung tumors. Presented at: 44th American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2008; Chicago, IL. Abstract 11112.
3. Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol. 2008;26(4):462-469.
4. Rosenwald S, Meiri E, Gilad S, et al. MicroRNA signature identifies tissue origin of primary and metastatic tumors. Presented at: 44th American Society of Clinical Oncology Annual Meeting; May 30-June 3, 2008; Chicago, IL. Abstract 11028.

1. Suzuki Y. Pathology of human malignant mesothelioma—preliminary analysis of 1,517 mesothelioma cases. Ind Health. 2001;39(2):183-185.
2. Klebe S, Mahar A, Henderson DW, Roggli VL. Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review. Mod Pathol. 2008;21(9):1084-1094.

1. Field RW, Smith BJ, Platz CE, et al. Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review. J Natl Cancer Inst. 2004;96(14):1105-1107.
2. Stang A, Pohlabeln H, Müller KM, Jahn I, Giersiepen K, Jöckel KH. Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study. Lung Cancer. 2006;52(1):29-36.